Our in vitro results are consistent with the global transcriptomic data set analysis [45], as we confirmed that invasive biphasic and sarcomatoid MPM cancer cells belong to neoplasms with overexpressed TYMS level, in turn predisposing them to targeted treatment that is accomplished by direct TYMS downregulation, including hampered transcription. Here, TYMS is linked to neoplasm.